Carl Zeiss reports €262.6 million in revenue in first quarter

Carl Zeiss Meditec reported €262.6 million in revenue in the first quarter of the fiscal year compared with €241.1 million reported in the same quarter of the previous fiscal year, according to a press release. Revenue in the Surgical Ophthalmology strategic business unit was reported at €92.6 million in the first quarter, a 13.6% increase from €81.6 million in the same quarter of the previous year.

Study shows possible genetic link to persistent retinal fluid in AMD

MIAMI — Persistent retinal fluid in eyes that have been treated with anti-VEGFs for neovascular age-related macular degeneration may have a genetic basis, a speaker told colleagues here.“Here we are, basically 10 years after anti-VEGF was introduced, and we’re seeing where the unmet needs are. Only 30%, a third of patients, who are treated gain three lines of vision. That would have been amazing 10 years ago, but we want more. About a third of patients also have persistent fluid after 1 year of treatment,” Philip J. Rosenfeld, MD, PhD, said at Angiogenesis, Exudation, and Degeneration 2016.